Previous close | 192.59 |
Open | 196.06 |
Bid | 190.82 x 800 |
Ask | 203.90 x 1000 |
Day's range | 194.10 - 199.12 |
52-week range | 181.36 - 308.15 |
Volume | |
Avg. volume | 563,996 |
Market cap | 10.108B |
Beta (5Y monthly) | 1.33 |
PE ratio (TTM) | 27.59 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
It might be of some concern to shareholders to see the Charles River Laboratories International, Inc. ( NYSE:CRL...
Charles River (CRL) launches cloud-based platform Apollo which enhances decision making abilities by providing real-time Toxicology study data.
Charles River's (CRL) newest addition, pHelper plasmid, targets simplifying the complex supply chains and cutting production timelines.